Phase Ib, IIa Study of Anti-Epidermal Growth Factor Receptor (EGFR) Antibody, Cetuximab, in Combination With Cemcitabine/Carboplatin in Patients With Chemotherapy-Naive Stage IV Non-Small Cell Lung Cancer.
Latest Information Update: 29 May 2023
At a glance
- Drugs Cetuximab (Primary) ; Carboplatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 31 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Oct 2009 Actual end date (1 Jan 2006) added as reported by ClinicalTrials.gov.